CivicKnodeCivicKnowA project of CivicKnode
Sign in

SB 218

Did not advanceConstitutional amendmentCrossfile HB 380
Add to calendar

Arbitration Reform for State Employees Act of 2023

Sponsor: Cory V. McCray (District 45)Committee: Budget and TaxationSubject: State Government - PersonnelStatus: Hearing 2/01 at 2:00 p.m. (Budget and Taxation) (as of Nov 9, 2023)

What this bill does

Official synopsis

Altering the collective bargaining process for State employees, including by requiring the selection of a neutral arbitrator to oversee all aspects of collective bargaining, establishing a process of arbitration in the event of impasse, and providing that certain decisions of a neutral arbitrator are advisory; requiring that each budget bill contain the appropriations necessary to implement all terms and conditions of employment in certain memoranda of understanding for the next ensuing fiscal year; etc.

AI analysis is off. Set ANTHROPIC_API_KEY to enable summaries, pros and cons, and questions.

Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.

Testimony (11)

MGA witness list
FAV 7FavorableUNF 4Unfavorable
PositionWitnessOrganizationTestimony
FAVMoran, PatrickAFSCMEOral + Written (PDF)
FAVPekny, JeanneAFSCME Local 1072Oral
FAVVick , CherrishAFSCME Local 112Oral
FAVEdwards, DonnaMaryland State & DC AFL-CIOWritten (PDF)
FAVBell, DestinyIndividualWritten (PDF)
FAVMaher, DavidlobbyistIndividualOral + Written (PDF)
FAVSenator McCray, Senator McCraylegislatorIndividualOral
UNFBenn, StaceyMorgan State UniversityWritten (PDF)
UNFYates, AnnaSt. Mary's College of MarylandWritten (PDF)
UNFHogan, PatricklobbyistUniversity System of MarylandOral + Written (PDF)
UNFRoxas, SherriUniversity System of Maryland OfficeOral

Organizations on record

Registered lobbyists who testified

FAVMaher, DavidRegistered for: AFSCME Council 3
UNFHogan, PatrickUniversity System of MarylandRegistered for: ALS Association, The; Adobe Inc.; Amgen, Inc.; Annie E. Casey Foundation, Inc., The; AstraZeneca Pharmaceuticals, LP; Capital One